openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Intersect ENT Inc (NASDAQ: XENT)

11-20-2019 02:20 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Intersect ENT Inc (NASDAQ: XENT) shares.

An investigation on behalf of current long term investors in Intersect ENT Inc (NASDAQ: XENT) shares.

An investigation was announced for investors in shares of Intersect ENT Inc (NASDAQ: XENT) concerning potential breaches of fiduciary duties by certain directors and officers of Intersect ENT Inc was announced.

Investors who are current long term investors in Intersect ENT Inc (NASDAQ: XENT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: XENT stocks follows a lawsuit filed against Intersect ENT Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: XENT stocks, concerns whether certain Intersect ENT Inc directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the defendants failed to disclose to investors that the Company lacked adequate reimbursement representatives to ensure physicians had access to SINUVA, that, as a result, the Company’s sales force would focus on ensuring reimbursement, that, as a result, the Company’s sales representatives were less focused on driving sales, that physicians were less likely to adopt the Company’s SINUVA due to transaction costs associated with seeking reimbursement, that the Company would increase staffing to address these issues, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Intersect ENT Inc (NASDAQ: XENT) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Intersect ENT Inc (NASDAQ: XENT) here

News-ID: 1869619 • Views: 168

More Releases from Shareholders Foundation

Lawsuit filed for Investors in Energy Transfer LP (NYSE: ET) over alleged Mislea …
An investor in Energy Transfer LP (NYSE: ET) filed a lawsuit over alleged violations of Federal Securities Laws by Energy Transfer LP in connection with certain allegedly false and misleading statements. Investors who purchased units of Energy Transfer LP (NYSE: ET) have certain options and for certain investors are short and strict deadlines running. Deadline: January 20, 2020. NYSE: ET investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investigation announced for Investors in shares of CBL & Associates Properties, …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at CBL & Associates Properties, Inc. Investors who purchased shares of CBL & Associates Properties, Inc (NYSE: CBL) and currently hold any of those NYSE: CBL shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain CBL & Associates Properties
Lawsuit filed for Investors in shares of Aurora Cannabis Inc. (NYSE: ACB)
The Shareholders Foundation announced that an investor, who purchased shares of Aurora Cannabis Inc. (NYSE: ACB), filed a lawsuit over alleged violations of Federal Securities Laws by Aurora Cannabis Inc. Investors who purchased shares of Aurora Cannabis Inc. (NYSE: ACB), have certain options and for certain investors are short and strict deadlines running. Deadline: January 21, 2020. NYSE: ACB investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779
Investigation announced for Long-Term Investors in shares of Verb Technology Com …
An investigation on behalf of current long-term investors in shares of Verb Technology Company, Inc. (NASDAQ: VERB) concerning potential breaches of fiduciary duties by certain directors and officers of Verb Technology Company, Inc. was announced. Investors who are current long term investors in Verb Technology Company, Inc. (NASDAQ: VERB) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a

All 5 Releases


More Releases for ENT

United States ENT Endoscopes Market Report
In this report, the United States ENT Endoscopes market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
ENT Chairs Market – Global Industry Insights, Trends
ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well
ENT Chairs Market – Global Industry Insights, 2025
ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well
2017 ENT Devices Market Embraces Advancements
In this report, the global ENT Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ENT Devices in these regions, from 2012 to 2022 (forecast), covering North
ENT 2017_Conference_New Orleans, USA
On behalf of Allied Academies, it is our pleasure to invite you all to the “5th American Otolaryngology - ENT Surgery Conference” during November 09-10, 2017. New Orleans, Louisiana, USA. The International conference offers a focus on “Emerging Trends and Innovations in Otolaryngology-ENT”. For more details, visit us: http://ent.alliedacademies.com/ The ENT 2017 will cover the various key issues related to Head and Neck such as Head and Neck Surgery, Otolaryngology (ENT),
Jacksonville ENT Surgery welcomes new Medical Assistant
Jacksonville, Fla., Feb. 15, 2017 – Jacksonville ENT Surgery is pleased to welcome Lejla Juklo to their team as a certified medical assistant. Juklo will be responsible for taking a patient’s medical history, vital signs, preparing rooms for patient exams, assisting with allergy testing, CT scans and assisting the providers. She will be rotating between Jacksonville ENT Surgery’s five locations in Jacksonville, Jacksonville Beach and Lake City. Juklo is a